Revealing the Patient Perspective: Evolution of Patient‐Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine
Steven Dayan(University of Illinois Chicago), Maria Musumeci, Jean Carruthers(University of British Columbia), Patricia Ogilvie, Yan Wu(Guangzhou University of Chinese Medicine), Elisabeth Lee(Allergan (Ireland)), Vaishali Patel(Amgen (United States)), Alexander Rivkin
Cited by 4
Related Papers
The P300 and reward valence, magnitude, and expectancy in outcome evaluation
|Brain Research|2009|474
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
|New England Journal of Medicine|2008|388
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel
|British Journal of Dermatology|2016|287
Global Aesthetics Consensus
|Plastic & Reconstructive Surgery|2016|249
Exposure of male mice to two kinds of organophosphate flame retardants (OPFRs) induced oxidative stress and endocrine disruption
|Environmental Toxicology and Pharmacology|2015|174